Enter your email address:

Delivered by FeedBurner

Human clinical trials of Gennova’s mRNA COVID-19 vaccine to start by the end of this year

Pune-based biotechnology company Gennova Biopharmaceuticals will soon
start human clinical trials of a Covid-19 vaccine candidate, joining
Bharat Biotech, Zydus Cadila and many global peers in the race for a
vaccine against the pandemic. Gennova is the first Indian company that
is working on an mRNA vaccine platform that US-based biotech company
Moderna's Covid-19 vaccine candidate is based. Gennova CEO Sanjay
Singh shared the company's plans with ET's Divya Rajagopal in an
interview. Edited excerpts follow.



Post a Comment